RABINTA-20
MRP: 110
Packaging: 20 MG
Pack Type: injection
Composition:
Rabeprazole 20mg
Indication:
Functional Dyspepsia, Diabetic Gastroparesis, Duodenal or gastric ulcers, Gastritis, GERD.
Description:
Rabeprazole 20 mg Injection is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by inhibiting the H⁺/K⁺ ATPase enzyme system at the secretory surface of gastric parietal cells. This reduces stomach acidity, helping to treat conditions like gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome, and erosive esophagitis.
It is primarily used when oral administration is not feasible, such as in critically ill patients or those with severe gastroesophageal conditions requiring rapid acid suppression.
Tags:
- Rapid acid suppression for gastric disorders
- Ideal for patients unable to take oral PPIs
- Effective in managing GERD and ulcers
- Supports healing of erosive esophagitis
- Useful in ICU and surgical care
Usage Information
Dosage
Route: Intravenous (IV) infusion or slow IV injection Dose: 20 mg once daily, diluted in appropriate solvent for infusion over 10-30 minutes Administered by healthcare professionals only Duration depends on clinical response
Side Effects
Headache Diarrhea or constipation Nausea Injection site reactions Rarely, dizziness or rash
Contraindications
Hypersensitivity to Rabeprazole or other PPIs Severe liver impairment Concomitant use with certain drugs needing acidic pH for absorption (use caution)
Availability
Rabeprazole 20 mg injection Injectable proton pump inhibitor Acid reflux injection GERD treatment injection Rabeprazole IV for ulcers Rabeprazole acid suppression